International Agency of Research on cancer (2010) GLOBOCAN 2008. Accessed on July 2023

Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014;26(2):123–41.

Article  PubMed  PubMed Central  Google Scholar 

Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primer. 2020;6(1):92.

Article  Google Scholar 

Niaz K, Maqbool F, Khan F, Bahadar H, Ismail Hassan F, Abdollahi M. Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer. Epidemiol Health. 2017;9(39):e2017009.

Article  Google Scholar 

Dhull AK, Atri R, Dhankhar R, Chauhan AK, Kaushal V. Major risk factors in head and neck cancer: a retrospective analysis of 12-year experiences. World J Oncol. 2018;9(3):80–4.

Article  PubMed  PubMed Central  Google Scholar 

Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol Mech Dis. 2009;4(1):49–70.

Article  CAS  Google Scholar 

Economopoulou P, de Bree R, Kotsantis I, Psyrri A. Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting. Front Oncol. 2019;29(9):827.

Article  Google Scholar 

Lo TH, Wang CP, Chen CN, Yang TL, Lou PJ, Ko JY, et al. Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma. Sci Rep. 2022;12(1):2048.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu YH, Lin PY, Yang JH, Kuo YS, Wu YC. Serum levels and positive rates of tumor biomarkers in oral precancer patients. J Formos Med Assoc. 2021;120(6):1324–31.

Article  CAS  PubMed  Google Scholar 

Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 2005;23(4):338–51.

Article  PubMed  Google Scholar 

Sozzi G, Conte D, Leon M, Cirincione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol. 2003;21(21):3902–8.

Article  CAS  PubMed  Google Scholar 

Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chassé E, et al. Circulating deoxyribonucleic acid as prognostic marker in non–small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol. 2004;22(20):4157–64.

Article  CAS  PubMed  Google Scholar 

Gal S, Fidler C, Lo YMD, Taylor M, Han C, Moore J, et al. Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer. 2004;90(6):1211–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Altimari A, Grigioni AD, Benedettini E, Gabusi E, Schiavina R, Martinell A, et al. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer. Am J Clin Pathol. 2008;129(5):756–62.

Article  CAS  PubMed  Google Scholar 

Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA. Clin Chim Acta. 2001;313(1–2):139–42.

Article  CAS  PubMed  Google Scholar 

Fernandez-Garcia D, Hills A, Page K, Hastings RK, Toghill B, Goddard KS, et al. Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer. Breast Cancer Res. 2019;21(1):149.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schröck A, Leisse A, de Vos L, Gevensleben H, Dröge F, Franzen A, et al. Free-circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients: an observational prospective cohort study. Clin Chem. 2017;63(7):1288–96.

Article  PubMed  Google Scholar 

Fleming CA, Jordan P, O’Leary DP, et al. Perioperative cell-free DNA trends predict recurrence of non-metastatic colorectal cancer significantly earlier than CEA trends over the first 2 years post-operatively in stage II and stage III colon cancer. Int J Colorectal Dis. 2022;37:1119–26.

Article  PubMed  Google Scholar 

Shukla D, Kale AD, Hallikerimath S, Yerramalla V, Subbiah V. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma? J Oral Maxillofac Surg. 2013;71(2):414–8.

Article  PubMed  Google Scholar 

Lin LH, Chang KW, Kao SY, Cheng HW, Liu CJ. Increased plasma circulating cell-free DNA could be a potential marker for oral cancer. Int J Mol Sci. 2018;19(11):3303.

Article  PubMed  PubMed Central  Google Scholar 

Babji D, Nayak R, Bhat K, Kotrashetti V. Cell-free tumor DNA: emerging reality in oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2019;23(2):273–9.

Article  PubMed  PubMed Central  Google Scholar 

Mazurek AM, Rutkowski T, Fiszer-Kierzkowska A, Małusecka E, Składowski K. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients. Oral Oncol. 2016;54:36–41.

Article  CAS  PubMed  Google Scholar 

Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14(9):985–90.

Article  CAS  PubMed  Google Scholar 

Wang W, Kong P, Ma G, Li L, Zhu J, Xia T, et al. Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget. 2017;8(26):43180–91.

Article  PubMed  PubMed Central  Google Scholar 

van Ginkel JH, Huibers MMH, van Es RJJ, de Bree R, Willems SM. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients. BMC Cancer. 2017;17(1):428.

Article  PubMed  PubMed Central  Google Scholar 

Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10(10):1003–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hilke FJ, Muyas F, Admard J, Kootz B, Nann D, Welz S, Rieß O, Zips D, Ossowski S, Schroeder C, Clasen K. Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy. Radiother Oncol. 2020;151:182–9.

Article  CAS  PubMed  Google Scholar 

Chikuie N, Urabe Y, Ueda T, Hamamoto T, Taruya T, Kono T, Yumii K, Takeno S. Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma. Sci Rep. 2022;12(1):9316.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flach S, Howarth K, Hackinger S, Pipinikas C, Ellis P, McLay K, et al. Liquid BIOpsy for MiNimal RESidual DiSease detection in head and neck squamous cell carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma. Br J Cancer. 2022;126(8):1186–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verma T, Kumari S, Mishra S, et al. Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma. Indian J Pathol Microbiol. 2020;63(4):521–6.

Article  PubMed  Google Scholar